Related by context. All words. (Click for frequent words.) 63 prednisone prednisolone plus 62 ADCS CGIC 62 serum phosphorous 62 Left Ventricular Ejection Fraction 61 Tasigna prolongs 61 bronchodilatory 61 bronchial hyperresponsiveness 61 culture supernatants 61 -#.# log# copies mL 61 tissue oxygenation 61 8mg/kg 60 endothelin antagonists 60 aplindore 60 4mg/kg 60 Index CDAI 60 PLX STROKE targeting 60 Secondary endpoints include 60 glucocorticoid induced 60 Montgomery Asberg Depression 60 urine albumin 60 activated partial thromboplastin 60 Fibromyalgia Impact Questionnaire 59 lymphocyte count 59 Kinoid 59 Secondary endpoints included 59 baseline FEV 59 Rating Scale MADRS 59 lactate dehydrogenase LDH 59 hemagglutination inhibition HAI 59 Shows Promise Against 59 Cardiorespiratory fitness 59 calculated creatinine clearance 59 receiving XGEVA 59 LAB CGRP 59 fructosamine 58 hematological parameters 58 Crohn Disease Activity 58 MSLT 58 Symptom severity 58 Primary endpoints 58 Alzheimer Disease Assessment 58 anaphylactic reactions bronchospasm 58 leucopenia 58 mcg BID 58 serum aminotransferase levels 58 FUSILEV enhances 58 Inventory BPI 58 cough dyspnea 58 hemoglobin A1c HbA1c 58 Hamilton Anxiety Scale 58 elevated transaminases 58 glycosylated hemoglobin levels 58 ug dose 58 metabolic alkalosis 58 sleep onset WASO 58 reduce serum phosphate 58 epoetin alpha 58 polysomnography PSG 58 repeat paracentesis 58 reactogenicity 58 morphometric vertebral fractures 58 Pharmacokinetic parameters 58 Health Assessment Questionnaire 58 AST ALT 58 mild renal insufficiency 57 Severity MSCS score 57 hypothalamic pituitary adrenal axis 57 recombinant PSMA vaccine 57 PEG IFN 57 desvenlafaxine succinate 57 insomnia somnolence 57 secondary efficacy endpoint 57 fasting plasma 57 Severity Index PASI 57 Main Outcome Measures 57 fractional shortening 57 IELT 57 glycosylated hemoglobin HbA1c 57 exhaled NO 57 Pseudomonas aeruginosa P. aeruginosa 57 aspartate aminotransferase AST 57 3mg/kg 57 aplastic anemia AA 57 Secondary efficacy endpoints 57 apolipoprotein B 57 plasma HCV RNA 57 lispro 57 left ventricular diastolic 57 plasma leptin 57 demonstrated clinically meaningful 57 intradermal injections 57 budesonide pMDI 57 nasal symptom 57 confirmed CCyR 57 Amgen Neulasta R 57 SGOT 57 SGPT 57 CYP#A# CYP#D# 57 clinically meaningful reductions 57 echocardiographic parameters 57 cell adhesion molecule 57 Mg Usa 57 Tumor Response 57 salivary cortisol 57 weekly subcutaneous injections 57 progression TTP 57 intravenous bolus 57 platelet dysfunction 57 Myocardial Perfusion Imaging 56 Scale PANSS 56 relapsed MM 56 intravascular hemolysis 56 administered cetrorelix 56 #mg/day [001] 56 Skin sterol 56 bioavailable testosterone 56 virological response 56 platelet aggregation inhibitors 56 Prognostic significance 56 triiodothyronine 56 Hill Rom enhancing 56 intratympanic 56 CCyR 56 albumin creatinine ratio 56 #.#/#.# mmHg [001] 56 pDC 56 oxygen saturation SpO2 56 nerve conduction velocity 56 pyrimidine nucleoside analog 56 biochemical relapse 56 luteinising hormone LH 56 Polysomnography 56 exhaled nitric oxide 56 serum leptin 56 fatigue abdominal pain 56 Endothelial function 56 bronchoalveolar lavage fluid 56 mg subcutaneous 56 serum IGF 56 nausea photophobia 56 LDL cholesterol HDL cholesterol 56 aspartate aminotransferase 56 corticosteroid dose 56 lispro alone 56 WOMAC pain 56 cerebral oxygenation 56 adrenocortical 56 BENICAR 56 tipranavir r 56 estimated glomerular filtration 56 SpO2 pulse rate 56 stimulated insulin secretion 56 LDL triglycerides 56 esophageal manometry 56 CYP#A# substrate 56 Abrupt discontinuation 56 intestinal mucosal 56 High Dose quadruples 56 pharmacokinetic equivalence 56 Mean Symptom Complex 56 Main Outcome Measure 56 atrial pacing 56 liver histology 56 prespecified secondary 56 haematologic 56 oral prednisolone 56 pharmacodynamic parameters 56 HBeAg seroconversion 55 alanine aminotransferase ALT 55 Forodesine HCl 55 -#.# mg dL [001] 55 Solid Tumors criteria 55 Brief Psychiatric 55 brand ciclesonide HFA 55 mg TID 55 hemodynamic measurements 55 torsade de pointes 55 plasminogen activator inhibitor 55 QTcF 55 Visual Analogue Scale VAS 55 unfractionated heparin UFH 55 daytime somnolence 55 log# IU mL 55 albumin excretion rate 55 elevated ALT 55 cisplatin gemcitabine 55 cEVR 55 5 Fluorouracil 55 Shows Efficacy 55 fluticasone salmeterol 55 infliximab monotherapy 55 Psoriasis Area 55 dose dependently 55 K ras mutations 55 humanized therapeutic 55 abacavir lamivudine 55 Apidra ® 55 Mg Uk 55 fasting plasma glucose FPG 55 Cathepsin B 55 ATACAND 55 symptomatic VTE 55 ancrod 55 serum bicarbonate 55 salmeterol fluticasone 55 glomerular filtration rate 55 Inhaled Nitric Oxide 55 hemodynamic variables 55 Insulin sensitizers 55 Neuropsychiatric Inventory NPI 55 collected saliva samples 55 NNRTI resistant virus 55 NPM1 mutation 55 denileukin diftitox 55 aPTT 55 nausea dizziness vomiting 55 approved incretin mimetic 55 deCODE AF TM 55 Myoglobin 55 Left Ventricular 55 bi phasic 55 Glomerular Filtration Rate 55 PLMS 55 C Reactive Protein 55 insulin glulisine 55 oxycodone CR 55 urinary albumin 55 Scale EDSS 55 methacholine challenge 55 Western blotting 55 Viral load 55 pharmacologically active isomer 55 Warfarin Coumadin 55 mitoxantrone plus 55 parasitemia 55 neutropenic sepsis 55 MCyR 55 esophageal acid 55 hyaluronidase enzyme 55 CIMZIA R 55 Score IPSS 55 response CCyR 55 certolizumab 55 plasma renin activity 55 ALT normalization 55 intraperitoneally 55 Global Impression CGI 55 PREZISTA r arm 55 pegylated alpha interferon 55 hemoglobin Hb 55 Monocyte 55 trough FEV1 55 Nebulized 55 Montgomery Åsberg Depression 55 PULMICORT RESPULES 55 tapentadol ER 55 Non inferiority 55 deep venous thromboses 55 polysomnographic 55 noradrenergic 55 Therapy Reduces 54 serum potassium 54 mcg QD 54 induced phosphorylation 54 moderate renal impairment 54 serum cortisol 54 cefotaxime 54 spirometric 54 Ambulatory Blood Pressure 54 wrist actigraphy 54 overt nephropathy 54 tissue oxygen saturation 54 #mg q8h 54 glulisine 54 Creatinine 54 frequent awakenings 54 creatinine ratio 54 mediated inhibition 54 overnight polysomnography 54 Biphasic 54 Cystatin C 54 x ULN 54 serum concentrations 54 #mg BID [003] 54 FOLFOX6 54 PLMs 54 noninvasively measures 54 + PH# 54 Secondary endpoints 54 CK # plasma concentrations 54 DAS# CRP 54 azilsartan medoxomil 54 Cystic Fibrosis Questionnaire Revised 54 Acetate Rectal Suppositories 54 bone marrow reticulin deposition 54 noninvasive outpatient 54 dyslipidemia abnormal 54 LPS induced 54 hyperalgesia 54 variant angina 54 bortezomib refractory 54 Somnolence 54 log# copies mL 54 proton MR spectroscopy 54 deoxy 54 Intrusion SecureNet TM 54 genotypic resistance 54 baseline serum creatinine 54 ADAS Cog 54 TIMP 1 54 jitter packet loss 54 ptau 54 Intravenous immunoglobulin 54 SSRI citalopram 54 de novo kidney transplant 54 ischemia driven 54 Scale cognitive subscale 54 Prospective Randomized 54 Omacetaxine 54 hemoglobin A1C HbA1C 54 thromboxane A2 54 transdermal estradiol 54 transaminase 54 Visual Analog Scale 54 eNO 54 CINQUIL 54 prospectively stratified 54 Fasting blood glucose 54 Known hypersensitivity 54 -#.# mg dL [002] 54 Achieves Primary Endpoint 54 triglyceride concentrations 54 glycated hemoglobin levels 54 rFSH 54 viral tropism 54 International Prostate Symptom 54 Sustained virologic response 54 abnormal clotting 54 QRS interval 54 receptor antagonism 54 PROCTOCORT ® Suppository Hydrocortisone 54 estramustine 54 specific antigen PSA 54 oral levofloxacin 54 peak plasma concentrations 54 Negative Syndrome 54 NSAID associated 54 urinary N telopeptide 54 achieved ACR# 54 Hematocrit 54 HBsAg 54 cromolyn sodium 54 fasting serum 54 SIMPADICO 54 6 phosphate dehydrogenase 54 Teriflunomide 54 pharmacodynamic effects 54 Investigational eFlow 54 IgG antibody 54 mean ± SEM 54 Undesirable alterations 54 R pramlintide acetate 54 Stress Testing 54 BMI z 54 mL sec 54 ALT elevation 54 Score DAS 54 CIMZIA TM 54 mg QD 54 QT intervals 54 pulmonary capillary wedge 54 maternal serum 54 airflow limitation 54 dose atorvastatin 54 statin monotherapy 54 plasma lipids 54 MoxDuo TM IR 54 inhibin B 54 Brief Pain 54 hypopneas 54 microsomal 54 Pain Intensity 53 antibody titer 53 electroencephalographic 53 expiratory flow 53 antiretroviral naive 53 PSADT 53 Risk Stratification 53 corrected QT interval 53 colorectal adenoma 53 shortens systolic ejection 53 DAS# scores 53 Active Ulcerative Colitis 53 metabolite concentrations 53 lumbar spine BMD 53 intermittent dosing 53 busulfan 53 Index CDAI score 53 APTIVUS r 53 P = .# 53 chronic thromboembolic pulmonary 53 EEG abnormalities 53 www.lpsvcs.com 53 glycated hemoglobin HbA1c 53 vasoactive 53 viral nucleic acids 53 triple nucleoside regimen 53 treatment naive genotype 53 Q2W 53 attracts EPCs circulating 53 acetazolamide 53 anagrelide 53 maximal tolerated 53 microgram kg 53 QTc intervals 53 PSA nadir 53 STRIDE PD 53 biologic antibody 53 DAS# remission 53 IgA antibody 53 tolterodine ER 53 R entecavir 53 severe exacerbations 53 recovery CRp 53 nicardipine 53 UPDRS motor 53 mL/min/#.# m 2 53 pH conductivity 53 lopinavir r arm 53 cis retinoic acid 53 serum PTH 53 transcranial Doppler ultrasound 53 neutrophil counts 53 nadroparin 53 avosentan 53 Blood Glucose Testing 53 Unified Parkinson Disease 53 Synaptic Plasticity 53 Nanometrics automated 53 locomotor activity 53 alanine aminotransferase 53 mcg mL 53 CIMZIA ™ 53 pressure monitoring ABPM 53 akinesia 53 GSTP1 53 baseline HbA1c 53 Univariate 53 ug ml 53 Helps Predict 53 atrioventricular block 53 mL kg 53 lopinavir ritonavir plus 53 mg/# hours 53 dipyridamole plus 53 mRNA encoding 53 PCWP 53 NPH insulin 53 apnea hypopnea 53 hormones ghrelin 53 OGTT 53 mediated dilation 53 diastolic blood pressures 53 inhaled budesonide 53 5mg/kg 53 dose proportionality 53 erlotinib Tarceva ® 53 platelet reactivity 53 transient insomnia 53 Echocardiographic 53 corticotrophin releasing hormone 53 oral hypoglycemic agent 53 Posaconazole 53 neurologic progression 53 nucleotide analog 53 β blocker 53 metformin sulfonylureas 53 GAMMAGARD 53 sulfonylurea metformin 53 uM 53 diabetic acidosis 53 Insulin sensitivity 53 CNS LS 53 HOMA IR 53 arterial oxygen saturation 53 nadolol 53 coronary stenosis 53 antidepressants fluoxetine 53 systolic ejection 53 Monitors Neonatal Monitors Fetal 53 serum phosphate 53 μg mL 53 complete cytogenetic response 53 dexamethasone Decadron 53 stage IIIb IV 53 APACHE II 53 annualized relapse 53 HDL triglycerides 53 NovoLog ® Mix 53 Spirometry 53 System IPSS 53 cardiac autonomic 53 severe neutropenia 53 EUFLEXXA R 53 glucose insulin 53 hour bronchodilation 53 IFN α 53 nasal aerosol 53 #mg sodium #mg [002] 53 hypophosphatemia 53 aminotransferase ALT 53 multivariable Cox 53 RRM1 53 innovative wafer probers 53 oral antidiabetes 53 OBPM 53 electrophysiologic 53 corticosteroid therapy 53 postoperative AF 53 saline placebo 53 Sodium oxybate 52 quantitative coronary angiography 52 atazanavir ritonavir 52 INVEGA ® 52 #dhTxB# 52 methotrexate monotherapy 52 Scale CNS 52 asystole 52 alpha1 antitrypsin deficiency 52 ionotropic 52 FEV1 forced expiratory 52 neurohormonal activation 52 pulse amplitude 52 Protein Linked 52 pulmonary exacerbations 52 Suppository Hydrocortisone Acetate Rectal 52 Ketoacidosis 52 postdose 52 euthymic patients 52 Rating Scale UPDRS 52 SRTI leader 52 discontinued Viread 52 CSBM 52 virologic breakthrough 52 Score MOS 52 needle electromyography procedures 52 fludarabine cyclophosphamide 52 Ejection Fraction 52 dalteparin 52 quickly delivers signification 52 interleukin IL -6 52 LDL HDL 52 Holter monitoring 52 adenosine diphosphate ADP 52 clinically meaningful improvement 52 CorVue ™ 52 ARB telmisartan 52 statistically significant reduction 52 apnea hypopnea index 52 LV ejection fraction 52 Cardiac Resynchronization 52 intravenous cyclophosphamide 52 -#.# ± [002] 52 nonfatal myocardial infarction MI 52 6MWD 52 baseline Hb 52 μg liter 52 QRS duration 52 EDARBI 52 Kaplan Meier estimates 52 electroencephalograms EEG 52 FGFR4 52 HER2 expression 52 cytochrome oxidase 52 CrCl 52 Expanded Disability Status 52 immunoglobulin G 52 Mycophenolate mofetil 52 aspirin clopidogrel 52 coagulation abnormalities 52 SELDI TOF MS 52 inhaled iloprost 52 prednisone prednisolone 52 vibrometer 52 FASLODEX #mg 52 mso font pitch 52 undetectable HBV DNA 52 polysomnogram 52 glycoprotein IIb IIIa inhibitor 52 BEXXAR Therapeutic Regimen 52 gain amplifiers VGAs 52 daily subcutaneous injections 52 serum estradiol 52 cholestasis 52 HIV treatments Reyataz 52 aminotransferase levels 52 underwent percutaneous coronary 52 Fasting plasma glucose 52 mania hypomania 52 intravenous REOLYSIN 52 YMRS 52 plus GP IIb 52 nausea vomiting cramps 52 Cmax 52 #mg #mg #mg [003] 52 Intravitreal 52 steroid dexamethasone 52 carotid intima media 52 daytime alertness 52 neuropsychological assessments 52 acromegalic patients 52 ADAS cog 52 lowest tertile 52 plus Copegus 52 lactate dehydrogenase 52 HBeAg negative patients 52 artery elasticity 52 left ventricular systolic 52 BY CYNTHIA H. 52 nanoliter scale 52 TNF alpha IL 52 intima media thickness IMT 52 bronchoalveolar lavage 52 intima media thickness 52 min -1 52 serum magnesium 52 IV bolus 52 Coronary Angiography 52 Myelosuppression 52 mL/min/#.# m2 52 systemic hypotension 52 phenothiazines 52 #ng/ml 52 Ankle Brachial Index 52 system REG1 consists 52 tetracycline antibiotic 52 Interference Detection 52 reintubation 52 radiotracer uptake 52 ara C 52 REYATAZ r arm 52 orally inhaled 52 pharmacokinetic parameters 52 PASI score 52 myocardial function 52 FluCAM arm 52 gastric acid secretion 52 spontaneous bowel movements 52 using Inovio MedPulser 52 leukopenia pancytopenia thrombocytopenia 52 function Langberg 52 urinary albumin excretion 52 glycated 52 erythrocyte sedimentation rate 52 receiving prophylactic anticoagulation 52 mcg linaclotide 52 ibuprofen acetaminophen 52 TURBT 52 partial remissions 52 placebo p = 52 mg XP# 52 Bacillus Calmette Guerin 52 tirofiban 52 Free Survival PFS 52 Systolic 52 viral kinetics 52 serum CRP 52 TAXUS p value 52 replicon 52 symptomatic DVT 52 Oxygen Saturation 52 cerebral perfusion 52 fatigue asthenia 52 Major Depressive Disorder MDD 52 Evaluable 52 D Dimer 52 nevirapine regimen 52 HAQ DI 52 dual endothelin receptor antagonist 52 PASI scores 52 anticholinergic agents 52 Altera Nebulizer System 52 leukocyte counts 52 CK MB 52 leukocyte count 52 administered subcutaneously 52 tumor progression TTP 52 somatostatin 52 nausea emesis 52 placebo PBO 52 Daptomycin 52 beta2 agonist 52 prolonged QT interval 52 #mg BID [001] 52 vascular reactivity 52 immunodiagnostic kits 52 A1PI 52 Pharmacodynamic 52 effector function 52 Arterial stiffness 52 vasopressor 52 specific alkaline phosphatase 52 erection hardness 52 IFN γ 52 clomipramine 52 CR nPR 52 FSH CTP 52 neurohormones 52 quetiapine risperidone 52 Melbourne measured #kbps 52 inhibit platelet function 52 hemodynamic parameters 52 serum lipid levels 52 #mg/day [002] 52 cTnI 52 #.#mg/dL 52 CDAI 51 Levaquin levofloxacin 51 actigraphy 51 catheter occlusion 51 metastatic carcinoid tumors 51 mg kg Hematide 51 subjective sleepiness 51 Angiographic 51 Plasma concentrations 51 CFQ R 51 gamma oscillations 51 Nampt 51 Loss Severity 51 AtuPLEX 51 Pegasys ® 51 glomerular filtration 51 SGRQ 51 SpMet 51 ug kg 51 mg hydrochlorothiazide 51 Company perfluorocarbon PFC 51 Multiparameter 51 euthyroid 51 Thal Dex 51 cardiac repolarization 51 serum lipid 51 Lupuzor ™ 51 permanently discontinue Vectibix 51 pmol L 51 containing abacavir 51 NIH CPSI 51 ischemia induced 51 tracheal intubation 51 Orally administered 51 physiologic parameters 51 PT INR 51 serum urate 51 methemoglobin SpMet 51 sumatriptan naproxen sodium 51 postprandial glucose 51 atorvastatin #mg 51 electroretinography 51 g trans fats 51 preintervention 51 TM carboxyhemoglobin SpCO 51 #mg ATC 51 pyridostigmine 51 neuropathy sensory 51 impaired endothelial 51 lipopolysaccharide 51 PANSS 51 ABILIFY Injection 51 Valcyte tablets 51 #mg/m# [002] 51 posttransplant 51 dimeglumine 51 exendin 4 51 azilsartan medoxomil plus 51 variceal hemorrhage 51 myocardial reperfusion 51 Haemoglobin A1c 51 INVEGA ™ 51 posttreatment 51 carotid artery intima media 51 clinically meaningful improvements 51 plasma cortisol 51 Index FSFI 51 polyglutamate 51 cardiac contractility 51 plasma concentrations 51 salmeterol fluticasone propionate 51 titrated glipizide 51 isoprostane 51 C telopeptide 51 baroreceptor 51 ZOLINZA 51 beta adrenergic receptor 51 serum cotinine 51 administered intramuscularly 51 induced platelet aggregation 51 Central Venous Catheter 51 interferon γ 51 waist circumference WC 51 liver enzymes ALT 51 Test Detects 51 dose escalation phase 51 mg/m2 dose 51 insulin detemir 51 intranasal formulation 51 PRTG Traffic Grapher 51 FOLPI 51 Usage Monitoring 51 laser Doppler 51 CD8 responses 51 macrophage inflammatory protein 51 PON1 51 nitrotyrosine 51 transgene expression 51 docetaxel Taxotere ® 51 adjunctive placebo 51 postintervention 51 hypopnea 51 Ancrod 51 nausea somnolence 51 ampules containing HGH 51 refractory ischemia 51 immune modulating 51 steroidogenic 51 intraobserver 51 HepaMate 51 NMP# protein 51 intravesical infusion therapy 51 Distress Scale 51 EEG EMG 51 Monitoring Capabilities 51 cerebral somatic oximeter 51 Simulect 51 RAPAMUNE 51 creatinine clearance CrCl 51 serum calcium levels 51 affective psychosis 51 Clinically significant 51 generator detaching 51 Intranasal 51 2 microglobulin 51 lipoprotein Lp 51 inotropic 51 HT 1A 51 Hospitalized Patients 51 #mg doses [002] 51 #mg/m# [001] 51 cyclosporine tacrolimus 51 Hb A1C 51 Hp2 2 51 peri procedural 51 RQ PCR 51 FFNS 51 blinded randomized placebo controlled 51 polysomnography 51 SELENA SLEDAI 51 methacholine 51 thyrotropin 51 subscale scores 51 potassium supplementation 51 pegylated IFN 51 pretest probability 51 Abbott ARCHITECT 51 Glomerular filtration rate 51 aminotransferases 51 ULORIC 51 HDRS 51 IOP lowering 51 xanthine oxidase inhibitor 51 MADRS score 51 platelet aggregation IPA 51 Scale Revised 51 Bispectral Index 51 potent triglyceride lowering 51 recurrent DVT 51 transfusion syndrome 51 sUA levels 51 EliA 51 sweat chloride 51 undergo percutaneous coronary 51 autoregulation 51 sustained virological response 51 Scintigraphy 51 topically administered 51 inhibiting renin 51 periodically reassessed 51 intravenously administered 51 Epworth Sleepiness Scale 51 hepatorenal syndrome 51 P selectin 51 unresectable HCC 51 Guidelines Issued 51 QTc prolongation 51 detectable HCV RNA 51 eosinophil count 51 paricalcitol 51 Quiescent current 51 randomized #:#:# 51 fibrin deposition 51 elective percutaneous coronary 51 pressurized metered dose 51 airway responsiveness 51 VerifyNow 51 pharmacokinetics PK 51 Von Willebrand 51 sodium nitroprusside 51 lanthanum carbonate 51 acute febrile 51 acellular pertussis DTaP 51 mild hepatic impairment 51 hypericin 51 allopregnanolone 51 isoproterenol 51 mg BID dose 51 fraction LVEF 51 subscore 51 #mg/kg [002] 51 nasopharyngeal swabs 51 postprandial blood glucose 51 #.#ng/ml 51 kg -1 51 creatine kinase MB 51 subthalamic 51 H2RAs 51 mild renal impairment 51 immune globulins 51 GLUT4 51 short acting bronchodilator 51 IRLS 51 serum triglyceride 51 #/#mg 51 intravenous iv 51 Peptide YY 51 dose Iluvien 51 normothermic 51 Hemospan R 51 Disease Activity 51 Sleep Patterns 51 psychophysiological 51 State Examination MMSE 51 umbilical artery 51 pooled comparator 51 SCIg 51 dactylitis 51 Insulin PH# 51 Coronary calcium 51 SpO2 51 inflammatory biomarkers 51 residual platelet reactivity 51 DLQI 51 log# reduction 51 cardiac perfusion 51 Beck Anxiety Inventory 51 Massive Scalability 51 bronchoconstriction 51 Xelox 51 pH ORP 51 subscores 51 statistically significant predictor 51 sUA 51 AGILECT R 51 anti Parkinsonian 50 calcium antagonists 50 Tissue Plasminogen Activator 50 visceral adiposity 50 rapid virologic response 50 â ‰ ¥ 50 immunoreactive 50 microalbumin 50 receiving FUSILEV 50 antiviral efficacy 50 anginal pain 50 DAS# [002] 50 neurosensory 50 cerebral oximeter 50 Xanafide 50 piperacillin tazobactam 50 Web Booking Concierge 50 chloride secretion 50 Functional Assessment 50 BMI percentiles 50 GI motility 50 VKORC1 50 VCAM 1 50 #.#mg/kg [002] 50 mineral density BMD 50 serum BDNF 50 5mg #mg 50 Y BOCS 50 induced sputum 50 SHBG levels 50 highest tertile 50 WEEK ENDING INDEX 50 Gentle Path compound 50 vecuronium 50 warfarin sodium 50 -#.# log# 50 edifoligide 50 6MWT